Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Frontiers in Medicine|January 10, 2017
Focus on Nintedanib in NSCLC and Other TumorsAnna Manzo, Guido Carillio, Agnese Montanino, et al.Critical Reviews in Oncology/Hematology|December 25, 2016
New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working GroupDiego Cortinovis, Vanesa Gregorc, Maria Rita Migliorino, et al.Expert Opinion on Investigational Drugs|August 14, 2013
Metformin in lung cancer: rationale for a combination therapyFloriana Morgillo, Ferdinando Carlo Sasso, Carminia Maria Della Corte, et al.Cancer Management and Research|April 24, 2013
Critical appraisal of the use of regorafenib in the management of colorectal cancerLucia Festino, Alessio Fabozzi, Anna Manzo, et al.International Journal of Molecular Sciences|September 22, 2017
Angiogenesis Inhibitors in NSCLCAnna Manzo, Agnese Montanino, Guido Carillio, et al.Critical Reviews in Oncology/Hematology|August 31, 2015
Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumorsPasqualina Giordano, Anna Manzo, Agnese Montanino, et al.Frontiers in Oncology|June 14, 2021
Angiogenesis Inhibitors in Small Cell Lung CancerAgnese Montanino, Anna Manzo, Guido Carillio, et al.Cancers|October 14, 2022
BRAF Inhibitors in Non-Small Cell Lung CancerVincenzo Sforza, Giuliano Palumbo, Priscilla Cascetta, et al.Cancers|September 10, 2021
RET Inhibitors in Non-Small-Cell Lung CancerPriscilla Cascetta, Vincenzo Sforza, Anna Manzo, et al.Cancer Control : Journal of the Moffitt Cancer Center|March 17, 2025
Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?Carmine Picone, Annamaria Porto, Roberta Fusco, et al.Pageof 3